The CDC's Stabilization Team Has Another Vacancy

The CDC's stabilization team is now recruiting for the stabilization team.

Deputy director and chief medical officer Jennifer Shuford is expected to leave on November 12, according to an agency email obtained by the Guardian. She joined the four-person leadership team appointed in April to help steady an institution already dealing with upheaval at the top. Dr. Satish Pillai will take over her duties on an acting basis while a successor is sought.

“Acting” is an important job description in Washington. It can also become an institution's longest-running production.

Shuford says she is leaving to spend more time with her family and thanked President Trump and Health Secretary Robert F. Kennedy Jr. for the opportunity. There is no need to invent a secret resignation speech for her. Her stated reason is family. The public question is what happens to the agency, not whether we can read an alternative explanation between lines that do not contain one.

The April appointments were presented as a restoration of scientific excellence. Shuford's selection drew praise from public-health leaders familiar with her work as Texas health commissioner. The administration had recruited credentials to help establish confidence.

Credentials are useful. Keeping an institution capable of using them is the less photogenic part.

The Guardian places the departure against a larger pattern of disruption: the agency has lost a third of its workforce, while Kennedy has replaced the CDC's expert vaccine advisory panel and the agency's vaccine messaging has become a source of conflict. Those are institutional conditions, not proof of Shuford's personal motive.

They matter because a public-health agency has work that cannot be put on hold until the next welcome email. Monitoring disease, maintaining credible information and retaining experienced staff require continuity. A new leadership announcement does not itself restore any of those functions, however impressive the degrees in the announcement.

CDC director Erica Schwartz praised Shuford's leadership in what she described as an exceptionally demanding and constantly evolving environment. That may be a gracious farewell. It is also not the description most people hope to hear about the management of the institution responsible for dependable public-health guidance.

A constantly evolving virus is a scientific problem. Constantly evolving senior management is not the treatment.

Pillai's acting appointment provides someone to do the job during the search. That is necessary and should not be mocked as evidence that he cannot do it. The accountability question belongs to the political leadership that promised to steady the agency: what has it built that will last beyond the next departure?

The CDC does not need another announcement that stability has arrived. It needs stability to stay long enough that nobody has to announce it.